The effectiveness of alendronate (70 mg weekly) in women with postmenopausal osteoporosis

被引：0
|
作者：
Martchenkova, L. A. [1 ]
Dreval, A. V. [1 ]
Kryukova, I. V. [1 ]
Tishenina, R. S. [1 ]
Milov, N. M. [1 ]
机构：
[1] Moscow Reg Res Clin Inst, Moscow, Russia
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Cyclical alendronate treatment in postmenopausal women with osteoporosis
    Kösüs, A
    Çapar, M
    Kösüs, N
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) : 182 - 184
  • [42] ALENDRONATE DISCONTINUATION IN POSTMENOPAUSAL WOMEN TREATED FOR OSTEOPOROSIS
    Powell, Diane
    Than, Soe Soe
    Butler, Robin
    Matthews, Clare
    Garton, Mark
    [J]. RHEUMATOLOGY, 2014, 53 : 133 - 134
  • [43] Alendronate improves QOL of postmenopausal women with osteoporosis
    Kawate, Hisaya
    Ohnaka, Keizo
    Adachi, Masahiro
    Kono, Suminori
    Ikematsu, Hideyuki
    Matsuo, Hisashi
    Higuchi, Kazumi
    Takayama, Takehiko
    Takayanagi, Ryoichi
    [J]. CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 123 - 131
  • [44] TREATMENT WITH ONCE-WEEKLY ALENDRONATE 70 MG COMPARED TO ONCE-WEEKLY RISEDRONATE 35 MG IN WOMEN WITH POSTMENOPAUSALE OSTEOPOROSIS: A RANDOMIZED DOUBLE-BLIND STUDY
    Pietschmann, Peter
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2005, 12 (01): : 36 - 38
  • [45] Persistence with weekly alendronate therapy among postmenopausal women
    J. C. Lo
    A. R. Pressman
    M. A. Omar
    B. Ettinger
    [J]. Osteoporosis International, 2006, 17 : 922 - 928
  • [46] Persistence with weekly alendronate therapy among postmenopausal women
    Lo, J. C.
    Pressman, A. R.
    Omar, M. A.
    Ettinger, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 (06) : 922 - 928
  • [47] The effectiveness of alendronate, risedronate and calcitonin treatment in postmenopausal osteoporosis
    Yildirim, K
    Güreser, G
    Karatay, S
    Senel, K
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S121 - S121
  • [48] Similar improvements in hip bone mineral density with monthly oral ibandronate (150mg) versus weekly oral alendronate (70mg) in postmenopausal osteoporosis
    Borges, J. L. C.
    Bolognese, M.
    Epstein, S.
    Sedarati, F.
    Neate, C.
    Miller, P. D.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S326 - S326
  • [49] Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.
    Palmisano, J
    Melton, M
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S24 - S24
  • [50] Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Mako, B
    Smith, ME
    Yates, J
    Palmisano, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S405 - S405
12345